Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Type:
Application
Filed:
July 18, 2016
Publication date:
March 2, 2017
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen Chang, Hsing-Mao Chu, Chun-Yu Lin
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Type:
Application
Filed:
September 1, 2016
Publication date:
March 2, 2017
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen CHANG, Hsing-Mao CHU, Li-Yun DU
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Type:
Application
Filed:
May 20, 2016
Publication date:
November 24, 2016
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen CHANG, Hsing-Mao CHU, Chien-Jen Lin, Chun-Yu Lin
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Type:
Application
Filed:
May 20, 2016
Publication date:
November 24, 2016
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen CHANG, Hsing-Mao CHU, Jou-Han CHEN, Li-Yun DU
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Type:
Application
Filed:
May 20, 2016
Publication date:
November 24, 2016
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen CHANG, Hsing-Mao CHU, Chien-Jen Lin, Chun-Yu Lin
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: Disclosed herein is an anti-migis-??antibody specific for the migis-? of human m? chain that can bind to mIgA on B lymphocytes, cause the lysis of mIgA-expressing B lymphocytes, and decrease IgA production by IgA-secreting B lymphocytes. Disclosed further is a pharmaceutical composition comprising the anti-migis-? antibody and a pharmaceutically acceptable carrier. Disclosed further is a method for lysing mIgA-expressing B lymphocytes and reducing IgA production in a human subject in vivo by employing an antibody specific for the migis-? of human m? chain that can bind to mIgA on B lymphocytes, cause the lysis of mIgA-expressing B lymphocytes, and decrease IgA production by IgA-secreting B lymphocytes.
Type:
Application
Filed:
June 3, 2016
Publication date:
October 6, 2016
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen CHANG, Alfur Fu-Hsin HUNG, Donic Chien-Sheng LU
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Type:
Application
Filed:
January 18, 2016
Publication date:
July 21, 2016
Applicant:
Immunwork Inc.
Inventors:
Tse-Wen Chang, Hsing-Mao Chu, Chun-Yu Lin
Abstract: The present disclosure provides various molecular constructs having a targeting element and/or an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.
Abstract: The present disclosure provides various molecular constructs having a targeting element and an effector element. Methods for treating various diseases using such molecular constructs are also disclosed.